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Thyroid hormone (TH) disrupting compounds are potentially important environmental contaminants
due to their possible adverse neurological and developmental effects on both humans and wildlife.
Currently, the most successful bio-analytical method to detect and evaluate TH disruptors, which target
the plasma transport of TH in environmental samples, is the radio-ligand thyroxine-transthyretin (T4-
TTR) binding assay. Yet, costly materials and tedious handling procedures prevent the use of this assay in
high throughput analysis that is nowadays urgently demanded in environmental quality assessment. For
the first time a miniaturized fluorescence T4-TTR binding assay was developed in a 96 well microplate
and tested with eight TH disrupting compounds. For most of the compounds, the sensitivity of the newly
developed assay was slightly lower than the radio-ligand binding assay, however, throughput was
enhanced at least 100-fold, while using much cheaper materials. The TH disrupting potency of 22 herring
gull (Larus argentatus) egg extracts, collected from two different locations (Musvær and Reiaren) in
Norway, was evaluated to demonstrate the applicability of the assay for environmental samples.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Over the past decade, research in the field of endocrine
disruption has greatly increased with regard to the occurrence of
endocrine disrupting compounds in the environment and their
effects in the ecosystem and humans (Crisp et al., 1998). Over ther Ltd. This is an open access articlyears, various end points such as estrogenic, androgenic, proges-
togenic, glucocorticoid and thyroidogenic activities (Crisp et al.,
1998) have been included in endocrine disruption studies. The
thyroid system comprises the hypothalamus, the pituitary and the
thyroid gland. It is vulnerable to endocrine-disrupting effects
through different mechanisms, such as binding of xenobiotics to
thyroid hormone (TH) transport proteins and interference with the
plasma hormone transport of THs (Boas et al., 2006). Together with
thyroxine-binding globulin (TBG), transthyretin (TTR) is one of the
most important plasma proteins associated with the transport of
THs such as thyroxine (3, 30, 5, 50-tetraiodo-L-thyronine, T4).e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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in the presence of various environmental contaminants, such as
hydroxylated polychlorinated biphenyls (OH-PCBs), perfluoroalkyl
and polyfluoroalkyl substances (PFASs), hydroxylated poly-
brominated diphenyl ethers (OH-PBDEs) and other brominated
flame retardants (BFRs); caused by their competition with the T4
binding to TTR (Gutleb et al., 2010; Weiss et al., 2009; Cao et al.,
2010; Hamers et al., 2006). Interference with the plasma trans-
port of THs may lead to disruption of the targeted transport and
metabolism of T4 that may ultimately lead to perturbations of
natural functions of THs in adults as well as maturation and
development in juvenile or fetal life stages of vertebrates (Miller
et al., 2009). Advanced bio-analytical methods have therefore
been developed to evaluate disruption of T4 transport. A classical
method to assess such an effect uses 125I labelled T4 as the radio-
active ligand in a competitive binding assay (Lans et al., 1993). The
method was successfully applied in many studies and showed good
sensitivity (Weiss et al., 2009; Meerts et al., 2000; Simon et al.,
2013). However, due to the costly radioactive ligand, relatively
complicated assay steps and safety issues related to the handling of
125I as a radioactive tracer, the throughput of this approach is still
rather limited. In addition to this classical radio-ligand binding
assay, other approaches such as the TR-CALUX (thyroid hormone
responsive chemically activated luciferase gene expression) assay
and the ANSA (8-anilino-1-naphthalenesulfonic acid ammonium)-
TTR competitive fluorescence displacement assay have been
developed to assess the TTR binding capacity of TH disruptors in the
environment (Monta~no et al., 2012; Huang et al., 2011). Similar to
the ANSA-TTR assay, another bioassay, based on a previous study
(Smith, 1977), has also been developed to investigate the binding of
OH-PBDEs to TH transport proteins (TTR and TBG) using the fluo-
rescence probe fluorescein isothiocyanate (FITC) associated to T4
(Ren and Guo, 2012). This assay was performed in cuvettes and the
reported sensitivity for OH-PBDEs was comparable to the radio-
ligand assay.
In the present study, the same principle of FITC-T4 was applied,
however in order to further enhance assay throughput, it was
miniaturized in a 96 well microplate format. First, the new down-
scaled protocol was optimized to achieve similar performance as
the assay performed in cuvettes. Then, the new protocol was tested
with eight compounds from seven different groups (OH-PCBs, OH-
PBDEs, BFRs, PFASs, bromophenols, phthalates and antibacterial
agents) known to interfere with the T4-TTR binding. The observed
activities were compared with those obtained in the classical radio-
ligand binding assay. The T4 displacing potency of herring gull ex-
tracts from two locations in Norway was evaluated using the new
protocol to demonstrate the applicability of the assay for testing
environmental samples. In addition, in order to further explain the
activities determined using the bioassay, target analysis of OH-PCBs
based on gas chromatography (GC) using electron capture detec-
tion (ECD) was performed for the most potent sample, as high
levels of PCBs have previously been detected in these samples
(Muusse et al., 2015).
2. Materials and methods
2.1. Chemicals
Fluorescein isothiocyanate (FITC, >90%) and L-thyroxine (T4,
>98%) were supplied by Sigma-Fluka (Zwijndrecht, The
Netherlands). Anhydrous pyridine (99.8%) and triethylamine
(>99%) were purchased from Sigma-Aldrich (Zwijndrecht, The
Netherlands). Water was obtained from a Milli-Q Reference Aþ
purification system (Millipore, Bedford, MA, USA). Per-
fluorooctanoic acid (PFOA, 96%) and triclosan were purchased fromSigma-Fluka. Perfluorooctanesulfonic acid (PFOS, 98%) was pur-
chased from RTI laboratories (Livonia, MI, USA). 2, 4, 6-
tribromophenol (2, 4, 6-TBP, 99%) were purchased from Riedel-de
Haen (Seelze, Germany). Mono (2-ethylhexyl) phthalate (MEHP,
100 mg/mL in methyl tert-butyl ether) was purchased from Cam-
bridge Isotope Laboratories (Andover, MA, USA). 2,20,3,40,5,50-hex-
achloro-4-biphenylol (4-OH-CB-146, 50 mg/mL in nonane),
2,20,4,40,5,50-hexachloro-3-biphenylol (3-OH-CB-153, 50 mg/mL in
nonane) and 2,20,3,30,40,5,50-heptachloro-4-biphenylol (4-OH-CB-
172, 50 mg/mL in nonane) were obtained from Wellington Labora-
tories (Guelph, ON, Canada). 2,3,30,40,5-pentachloro-4-biphenylol
(4-OH-CB-107, 0.99 mg/g in 4-methyl-2-pentanol), 2,20,3,40,5,50,6-
heptachloro-4-biphenylol (4-OH-CB-187, 2 mg/g in 4-methyl-2-
pentanol), 6-hydroxy-2,20,4,40-tetrabromodiphenyl ether (6-OH-
BDE-47,1mg/mL in dimethyl sulfoxide) and tetrabromobisphenol A
(TBBPA, 1 mg/mL in dimethyl sulfoxide) were obtained from the
group of Prof. Bergman, ACES, Stockholm University, Sweden.
2.2. Synthesis of the fluorescent probe
The fluorescent labelled thyroxine (FITC-T4) has been synthe-
sized and purified according to a previous study (Smith, 1977). In
short, 51.4 mM of FITC reacted with 25.7 mM of L-thyroxine in a
pyridine/water/triethylamine medium (9:1.5:0.1, v/v/v) for one
hour at 37 C. The reaction products were precipitated by adding
20 vol of 0.2 M ammonium acetate buffer and collected after
centrifugation (10 min, 1000  g, Biofuge Stratos, Heraeus In-
struments, Hanau, Germany). After removal of the supernatant, the
precipitate was washed with 20 vol of MilliQ water and centrifuged
again at the same condition. The precipitate was then re-dissolved
in 8 vol of 0.005 M of ammonium bicarbonate. A few drops of
ammonia solution (10%, v/v) were added until the precipitate dis-
solved. The obtained solution was applied to a Sephadex G-50 fine
column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) which
was previously equilibrated with a solution of 5 mM ammonium
bicarbonate. The fluorescent impurities were thereafter removed
by washing the column with 10 column volumes of 5 mM ammo-
nium bicarbonate solution. The purified product (FITC-T4) was
eluted from the gel using MilliQ water and then freeze dried for
48 h under 0.7 mbar, 20 C. Before use, the obtained FITC-T4 was
dissolved in Tris-NaCl buffer (50 mM TrisHCl/100 mM NaCl, pH
7.4) and its concentration was measured by absorbance at 490 nm
using a Smartspec 3000 spectrophotometer (Bio-Rad Laboratories,
Hercules, CA, USA).
2.3. Herring gull egg collection and extraction
Sample collection and extraction was described in a previous
study (Muusse et al., 2015). During spring 2012, 22 herring gull
(Larus argentatus) eggs were collected from two locations in Nor-
way: 1) the Musvær Island (69520N, 18330E), a remote island in
the north of the country in the municipality of Tromsø and 2) the
Reiaren Island (5980N, 10270E), a more populated area off the
southeastern coast in the municipality of Tjøme. After collection all
the eggs were frozen as fast as possible in order to prevent embryo
development. Each egg was collected from a different nest without
knowing the age. The egg yolk extraction was performed in an ul-
trasonic bath for 15 min with acetone and cyclohexane (3:2, v/v).
After shaking for 1 h, the extracts were centrifuged for 10 min
(1300g) and the lipids were removed by gel permeation chro-
matography (GPC; Waters 2695 separations module coupled to a
Waters 486 absorbance detector at 254 nm) fitted with Envirogel
columns (19 mm  150 mm þ 19 mm  300 mm; Waters). The
extracts were collected between 14.40 and 21.00 min and the
dichloromethane used as mobile phase was evaporated under a
Fig. 1. Fluorescence measurements (n ¼ 3) at different substrate (FITC-T4) concen-
trations for the saturation study.
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dimethyl sulfoxide (purity 99.8%, SigmaeAldrich) for the bioassay.
2.4. Miniaturization of the TTR binding assay
The previous study (Ren and Guo, 2012) uses the TTR binding
assay in cuvettes to measure the fluorescent labelled T4 (FITC-T4)
that binds to TTR by fluorescence enhancement. In this study, the
protocol was downscaled to 96 well microplates (Greiner Bio-One,
Frickenhausen, Germany), to support high throughput screening in
e.g. effect-directed analysis (EDA) of complex environmental sam-
ples (Brack, 2003). Different materials (polypropylene, polystyrene)
and well shapes (flat bottom, round bottom and V bottom) of
microplates were tested. A white polypropylene plate with flat
bottom wells was selected due to relatively lower T4 adsorption to
the wall of the wells and good fluorescence measurement property.
In thewell, 14.5 mL of 1 mMFITC-T4, 8 mL of 3.6 mMTTR together with
80 mL of Tris-NaCl buffer was incubated for 5 min at room tem-
perature. In each experiment, two sets of blanks (n ¼ 3) were
simultaneously tested in the same plate to estimate the percentage
of replacement (T4 displacing potency of the inhibitor) and to
correct the original fluorescence caused by free FITC-T4. The FITC-T4
-only blank (Blank 1) was prepared by 14.5 mL of 1 mM FITC-T4 and
98 mL of Tris-NaCl buffer. The FITC-T4-TTR blank (Blank 2) was
prepared by ml of 1 mM FITC-T4, 8 mL of 3.6 mM TTR together with
90 mL Tris-NaCl buffer. Afterwards, 10 mL of the competitor to be
tested (either a single compound, an egg extract or the buffer for
the control wells, n ¼ 3) was added and the fluorescence intensity
was measured at 490 nm for the excitationwavelength and 518 nm
for the emission wavelength using a Varioskan Flash multimode
plate reader (Thermo Fisher Scientific, Waltham, MA, USA).
2.5. Data analysis of the assay
All the curve plotting and statistical treatment were carried out
with the software GraphPad Prism 6 (GraphPad software, San
Diego, CA, USA). In order to calculate the dissociation constant (Kd)
between T4 and TTR, a saturation studywas performed as described
by Ren and Guo (2012). The protocol was conducted in the same
way as the inhibition assay except that five different concentrations
of substrate (FITC-T4, from 0.025 mM to 1.0 mM) were tested at a
fixed TTR concentration (1 mM). The saturation study curve-fitting
to the data was performed by the “One site e Specific binding
with Hill slope” model.
The T4 displacing potency of the tested compounds or the ex-
tracts was estimated by the percentage of fluorescence intensity,
after the inhibitors (or extracts) had been introduced. The per-
centage was calculated by Equation (1):
ε ¼ IS  IB1
IB2  IB1
 100% (1)
In the equation, ε is the fluorescence intensity in percentage. IS is
the fluorescence detected in the wells containing single compound
or extract, together with FITC-T4 and TTR. IB1 and IB2 are the fluo-
rescence detected in the wells of Blank 1 and Blank 2, as defined in
section 2.4.
The dose response curves were obtained using the “log (inhib-
itor) vs. response (three parameters)” model (n ¼ 3) and the IC50
values were determined by the GraphPad Prism 6 software with
95% confidence. The IC50 value represents the concentration of an
inhibitor that is required for 50% inhibition. The concentration
range chosen for most of the inhibitors in the dose response ex-
periments was 1 pMe100 mM. The GraphPad Prism software was
used to plot the curves and find appropriate fittings. The T4EQvalues (g/g, lipid) of the tested herring gull egg samples were
calculated based on their measured T4 displacing potencies and
their lipid weights measured in a previous study (Muusse et al.,
2014).
2.6. Target analysis of five OH-PCBs
Target analysis of five OH-PCBs (4-OH-CB-107, 4-OH-CB-146, 3-
OH-CB-153, 4-OH-CB-172 and 4-OH-CB-187) was performed for
six egg extracts (sample 15, 16, 19, 22, 23, 24) and an extraction
blank. Prior to the GC analysis, partitioning and derivatization of
the aqueous fractions were performed according to the method
developed by Hovander et al. (2000). The five OH-PCBs were
subsequently analysed by an Agilent 6890 GC equipped with an
electron capture detector (ECD, Agilent Technologies, Palo Alto,
CA, USA) on a CP-Sil-8CB (25 m  0.15 mm i.d., 0.12 mm film
thickness, Agilent) column using hydrogen as carrier gas and ni-
trogen as makeup gas. The column-oven temperature program
was: 60 C (2 min), 50 C/min up to 200 C (0 min), 1 C/min up to
230 C (0 min), and 30 C/min up to 300 C (3min) (Meijer et al.,
2008).
3. Results and discussion
3.1. Saturation study
The curve obtained in the saturation study (Fig. 1) achieved a
similar shape as reported by Ren and Guo (2012) that allowed the
calculation of the FITC-T4 and TTR dissociation constant (Kd). The Kd
obtained in this study was equal to 261 mM (R2 ¼ 0.99).
3.2. TTR disrupting compounds tested using the miniaturized FITC-
T4/TTR binding assay
In total the T4 displacing potency of eight compounds from
seven selected groups of chemicals together with non-labelled T4
was quantitatively determined by a concentration response ex-
periments (n ¼ 3) using the miniaturized FITC-T4/TTR binding
assay. A concentration-dependent decrease in T4 binding to the TTR
was observed for all the tested compounds (Fig. 2). Among the
tested compounds, 4-OH-CB-107, TBBPA, 6-OH-BDE-47, PFOS, PFOA
and 2,4,6-TBP are well-known TH disrupting compounds and their
TTR binding potencies have previously been evaluated using the
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Cao et al., 2010; Hamers et al., 2006; Meerts et al., 2000).
In the miniaturized FITC-T4/TTR assay, 4-OH-CB-107 showed a
partial concentration-response curve, which was likely caused by
the water solubility of the compound (0.2 mM), plus the initial
solvent of 4-OH-CB-107 (4-methyl-2-pentanol) that was also
poorly miscible with the aqueous working medium of the assay.
Triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol) also dis-
played a concentration-dependent displacement of T4 from TTR,
which was consistent with a dose-dependent decreases in total
plasma T4 in rats exposed to the same compound via oral exposure
(Crofton et al., 2007); its T4 displacing potency was determined by
the radio-ligand binding assay in a recent study (Weiss et al.,
2015). For MEHP, the concentration in human urine was found
to be negatively correlated to the free T4 and T3 levels in serum
(Meeker et al., 2007). Therefore, MEHP was also expected to be a
TH disrupting compound. In this assay, MEHP was proven to
disrupt T4/TTR binding according to the dose response curve,
although the potency was relatively low compared to the other
compounds in this study.
The binding potencies of the eight compounds were evaluated
by their IC50 values, calculated from the corresponding dose
response curves, and were compared with the IC50 values obtained
from the radio-ligand binding assay (Table 1). The IC50 value of non-
labelled T4 and 4-OH-BDE-47 obtained in the miniaturized FITC-T4/
TTR assay (262 nM and 430 nM) were very close to the original
report of the FITC-T4/TTR assay performed in cuvette (260 ± 13 nMTable 1
IC50 values of T4 and the eight tested compounds obtained using non-labelled T4 mea
binding assay (RL-TTR).
Compounds IC50 miniFlu-TTR (mM)
4-OH-CB-107 0.24
TBBPA 0.22
6-OH-BDE-47 0.43
PFOS 1.21
PFOA 2.02
Triclosan 0.93
2,4,6-TBP 0.50
MEHP 13.08
T4 0.26
a Data from the EU FP7 project DENAMIC (Developmental Neurotoxicity Assessmand 323 ± 10 nM) (Ren and Guo, 2012), implying a successful
miniaturization. Comparing with the values achieved by the radio-
ligand binding assay, the IC50 values of the most potent compounds
(4-OH-CB-107, TBBPA and 2,4,6-TBP) measured by the miniaturized
FITC-T4/TTR assay were about 7e10 times higher. For the medium
potent compounds (6-OH-BDE-47, PFOS, PFOA and non-labelled
T4), the IC50 values were also higher but only by a factor of 1e3.
For the least potent compounds (triclosan and MEHP), the IC50
values were lower, indicating a possible higher sensitivity for these
two compounds of a factor 2.5. For all nine compounds, a linear
regression was performed for their IC50 values obtained by the two
methods. A slope of (IC50 radio-ligand assay as X and miniaturized
IC50 FITC-T4/TTR assay as Y) 0.40 was calculated with a R2 value of
0.9845.
3.3. Assessment of the TTR disrupting potency of herring gull egg
extracts
Twenty-two herring gull egg extracts, collected from two
different locations were tested with the miniaturized FITC-T4/TTR
assay. The percentage of inhibition was determined by one minus
percentage of fluorescence intensity. The experiments were per-
formed in triplicate. All individual extracts interfered with T4-TTR
binding, although the T4 displacing potency was considerably
different between individual eggs (Fig. 3A). This observation is
logical considering the long distance migration behavior of Euro-
pean herring gulls. An apparent trend in T4 displacing potency wassured in the miniaturized FITC-T4/TTR assay (miniFlu-TTR) and the radio-ligand
IC50 RL-TTR (mM) RL-TTR Reference
0.024 Meerts et al. (2002)
0.031 Hamers et al. (2006)
0.18 Hamers et al. (2006)
0.94 Weiss et al. (2009)
0.95 Weiss et al. (2009)
2.84 Weiss et al. (2015)
0.068 Meerts et al. (2000)
31.55 DENAMICa
0.08 Meerts et al. (2000)
ent of Mixtures in Children, http://www.denamic-project.eu/).
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Musvær Island than from Reiaren Island, albeit this difference was
not statistically significant due to large intra-group variance.
Similarly, a lower aryl hydrocarbon receptor agonist potential
was found in the eggs sampled from Musvær Island in a previous
study (Muusse et al., 2015), suggesting a possible generally lower
pollutant load at Musvær Island. In addition, a full concentration
response curve (CRC) was obtained for a representative extract
(sample 17, Fig. 3B). The TH disrupting activity (inhibition) of the
samples was interpolated with the T4 dose response curve in Fig. 2
to create the T4 equivalent quotients (T4EQ) for the sample
(Table 2). As TH disruption is still a relatively less studied endpoint
in environmental research, no T4EQ value has been reported so far
from similar matrices. Nevertheless, Suzuki et al. (2007). reported
that the TTR-binding potencies in indoor dusts collected from Japan
were roughly 250e4100 ng/g (median value 820 ng/g).Table 2
Weight, lipid content (Muusse et al., 2014) and T4EQ Values (mol/L in extract and g/g in lip
17, 21 and 23 were above the value range of the curve thus the maximum concentration
No. Location Weight (g) %Lipid
1 Musvær 34.78 24.70
2 30.76 27.09
4 28.05 24.35
5 29.37 29.08
6 25.13 30.07
7 25.73 35.72
8 24.26 32.04
9 23.59 31.07
10 30.02 26.27
11 Reiaren 28.01 28.79
12 28.58 23.72
13 28.00 22.20
14 30.56 19.07
15 30.97 22.06
16 22.74 25.21
17 34.96 18.78
18 31.14 21.29
19 51.91 11.60
20 29.84 19.79
21 32.94 17.54
22 48.01 10.79
23 47.05 13.43
Average3.4. OH-PCBs analysis of the selected samples
OH-PCBs are widely present TH disruptors in the environment.
The five OH-PCBs for target analysis were chosen based on their
relatively high concentrations detected in previous studies in
seabird eggs (Berger et al., 2004; Verreault et al., 2005; F€angstr€om
et al., 2005). With the analytical method used, the limits of detec-
tion (LODs) for 4-OH-CB-107, 4-OH-CB-146, 3-OH-CB-153, 4-OH-
CB-172 and 4-OH-CB-187 were 0.49 ng, 0.48 ng, 0.55 ng, 0.29 ng,
and 0.07 ng respectively, per injection in GC. None of the OH-PCBs
were detected above the LODs in the six extracts, suggesting the
presence of other TH disruptors. Although TH disruption has
received increasing attention the recent years, comparing with
other endpoints of endocrine disruption such as the well-studied
and extensively documented estrogenic activity, only limited
knowledge about potential TTR binders in the environment existid) of the 22 egg samples from two locations. The detected activities in sample 15, 16,
of T4 in the curve was used.
Lipid (g/egg) T4EQ (mol/L, extract) T4EQ (g/g, lipid)
8.59 1.02E-07 1.46E-08
8.33 3.63E-07 5.34E-08
6.83 5.30E-08 9.51E-09
8.54 6.58E-08 9.44E-09
7.86 8.18E-07 1.27E-07
9.19 5.38E-07 7.17E-08
7.77 4.39E-07 6.93E-08
7.33 5.42E-06 9.07E-07
7.89 7.21E-07 1.12E-07
8.06 3.83E-07 5.82E-08
6.78 1.79E-06 3.23E-07
6.22 9.35E-08 1.84E-08
5.83 8.64E-07 1.82E-07
6.83 >1.75E-05 >3.14E-06
5.73 >1.75E-05 >3.74E-06
6.57 1.68E-05 3.14E-06
6.63 8.72E-06 1.61E-06
6.02 8.24E-07 1.68E-07
5.91 7.86E-06 1.63E-06
5.78 >1.75E-05 >3.71E-06
5.18 9.42E-06 2.23E-06
6.32 >1.75E-05 >3.39E-06
1.12E-06
Table 3
A comparison of the cost and time of the developed miniaturized fluorescence T4-TTR (miniFlu-TTR) binding assay and the classical 125I radio-ligand (RL-TTR) binding assay.
Assay Cost of the ligands Incubation Format
miniFlu-TTR V40 per 100 mg (FITC) 5 min 96 well microplate
RL-TTR V780 per 100 mCi (0.3 mCi/mL, [125I]T4) >8 h vial
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that the transport protein TTR is susceptible to interference from a
large number of compounds including pollutant metabolites. Of
these compounds, OH-PBDEs, BFRs or PFASs may be sufficiently
persistent and bio-accumulative to enrich in bird eggs and warrant
targeted analysis in future initiatives (Gutleb et al., 2010; Cao et al.,
2010; Lans et al., 1993; Chauhan et al., 2000).
3.5. Considerations
The thyroid system is a rather complex system. Disruption of TH
transport is only one way a chemical can interfere with the thyroid
hormonal system. Other pathways include interference with TH
synthesis, the cellular uptake mechanisms, the TH receptor, the
iodothyronine deiodinases, and the metabolism of THs in the liver
(Boas et al., 2006). Due to their structural similarities with THs, it is
not surprising that (poly)hydroxylated metabolites of halogenated
aromatic hydrocarbons would mainly interfere with TH transport.
Measuring the disturbance of binding between T4 and TTR is
therefore relevant to understand the impact of metabolites coming
of halogenated aromatic hydrocarbons. Compounds disrupting TH
transport have been found in mature organisms, but their impact is
greater in non-mature organisms (Gutleb et al., 2010; Ucan-Marín
et al., 2009).
The intrinsic drawback of using in vitro bioassays to evaluate
environmental samples is that no information on the identity of the
compounds causing the observed effect is obtained. For an endo-
crine disruption endpoint like TH disruption, which has not yet
been comprehensively studied, the target analysis of known dis-
ruptors alone is apparently not sufficient. The recent developments
in high throughput effect-directed analysis (EDA) are expected to
address this problem by applying finer fractionation powered by
novel liquid chromatography techniques such as ultra-performance
liquid chromatography (UPLC) and comprehensive two dimen-
sional liquid chromatography (LC  LC) (Ouyang et al., 2016; Booij
et al., 2014), for which a fast and cost efficient bioassay is
required. Comparing with the classical 125I radio-ligand binding
assay, the developed miniaturized fluorescence T4-TTR binding
assay is much more suitable for high throughput EDA with a thy-
roidogenic end point (Table 3), for its lower cost of ligands, shorter
incubation time and 96 well microplate format that is compatible
with high resolution fractionation.
4. Conclusion
Although there are several assays available to measure TH
disruption, none of the assays is easy to use, cheap and very suitable
for the application to environmental samples. The miniaturization
of the FITC-T4/TTR assay into 96 well format developed in the
present study offers the possibility of rapid screening of TH dis-
rupting potencies in hundreds of environmental samples within a
few hours. Compared to the classical radio-ligand binding assay, the
FITC-T4/TTR assay is especially suitable for high throughput EDA,
due to the much lower costs of the ligand used, the shorter incu-
bation time, and easier handling procedures. The sensitivities of T4
and the eight tested compounds in the assay are slightly different
from that of the radio-ligand binding assay. For themost potent TTR
disrupting compounds (IC50 < 100 nM in radio-ligand bindingassay), the sensitivity was roughly one order of magnitude lower.
Possibly, this may be attributed to the relatively lower binding af-
finity of the probe caused by the steric hindrance of the FITC
moiety. It suggests that the assay is more suitable for screening
samples that can be easily obtained in relatively large quantities,
such as water and sediment samples. For the less potent com-
pounds (IC50  100 nM in the radio-ligand binding assay), the
sensitivities achieved by the two methods were similar.
The assay was successfully applied for the analysis of 22 extracts
of herring gull eggs from two locations in Norway. All extracts
showed activity in the assay. On average, the egg extracts collected
from the southeastern coast of the Norway showed much higher
inhibition than those collected from an island in the Arctic. Target
analysis of five OH-PCBs was performed for a selection of six
samples using GC-ECD but none of the OH-PCBs were detected
above the LODs, suggesting the possible presence of other TH dis-
rupting compounds.
Acknowledgements
Financial support from the EUMarie Curie EDA-EMERGE project
(EU contract 290100), FORMAS MiSSE project (Swedish Research
Council, 210-2012-131) and the Research Council of Norway are
gratefully acknowledged. The authors thank Martine Muusse for
preparing the egg extracts.
References
Berger, U., Herzke, D., Sandanger, T.M., 2004. Anal. Chem. 76, 441e452.
Boas, M., Feldt-Rasmussen, U., Skakkebæk, N.E., Main, K.M., 2006. Eur. J. Endocrinol.
154, 599e611.
Booij, P., Vethaak, A.D., Leonards, P.E.G., Sjollema, S.B., Kool, J., de Voogt, P.,
Lamoree, M.H., 2014. Environ. Sci. Technol. 48, 8003e8011.
Brack, W., 2003. Anal. Bioanal. Chem. 377, 397e407.
Cao, J., Lin, Y., Guo, L.-H., Zhang, A.-Q., Wei, Y., Yang, Y., 2010. Toxicology 277, 20e28.
Chauhan, K.R., Kodavanti, P.R., McKinney, J.D., 2000. Toxicol. Appl. Pharmacol. 162,
10e21.
Crisp, T.M., Clegg, E.D., Cooper, R.L., Wood, W.P., Anderson, D.G., Baetcke, K.P.,
Hoffmann, J.L., Morrow, M.S., Rodier, D.J., Schaeffer, J.E., Touart, L.W.,
Zeeman, M.G., Patel, Y.M., 1998. Environ. Health Perspect. 106 (Suppl. l), 11e56.
Crofton, K.M., Paul, K.B., DeVito, M.J., Hedge, J.M., 2007. Environ. Toxicol. Pharmacol.
24, 194e197.
F€angstr€om, B., Athanasiadou, M., Athanassiadis, I., Weihe, P., Bergman, A., 2005.
Ambio 34, 184e187.
Gutleb, A.C., Cenijn, P., Van Velzen, M., Lie, E., Ropstad, E., Skaare, J.U., Malmberg, T.,
Bergman, Å., Gabrielsen, G.W., Legler, J., 2010. Environ. Sci. Technol. 44,
3149e3154.
Hamers, T., Kamstra, J.H., Sonneveld, E., Murk, A.J., Kester, M.H.A., Andersson, P.L.,
Legler, J., Brouwer, A., 2006. Toxicol. Sci. 92, 157e173.
Hovander, L., Athanasiadou, M., Asplund, L., Jensen, S., Wehler, E.K., 2000. J. Anal.
Toxicol. 24, 696e703.
Huang, R., Xia, M., Cho, M.H., Sakamuru, S., Shinn, P., Houck, K.A., Dix, D.J.,
Judson, R.S., Witt, K.L., Kavlock, R.J., Tice, R.R., Austin, C.P., 2011. Environ. Health
Perspect. 119, 1142e1148.
Lans, M.C., Klasson-Wehler, E., Willemsen, M., Meussen, E., Safe, S., Brouwer, A.,
1993. Chem. Biol. Interact. 88, 7e21.
Meeker, J.D., Calafat, A.M., Hauser, R., 2007. Environ. Health Perspect. 115,
1029e1034.
Meerts, I.A., van Zanden, J.J., Luijks, E.A., van Leeuwen-Bol, I., Marsh, G.,
Jakobsson, E., Bergman, A., Brouwer, A., 2000. Toxicol. Sci. 56, 95e104.
Meerts, I.A.T.M., Assink, Y., Cenijn, P.H., Van Den Berg, J.H.J., Weijers, B.M.,
Bergman, A., Koeman, J.H., Brouwer, A., 2002. Toxicol. Sci. 68, 361e371.
Meijer, L., Weiss, J., Van Velzen, M., Beouwer, A., Bergman, Å.K.E., Sauer, P.J.J., 2008.
Environ. Sci. Technol. 42, 3428e3433.
Miller, M.D., Crofton, K.M., Rice, D.C., Zoeller, R.T., 2009. Environ. Health Perspect.
117, 1033e1041.
Monta~no, M., Cocco, E., Guignard, C., Marsh, G., Hoffmann, L., Bergman, A.,
X. Ouyang et al. / Chemosphere 171 (2017) 722e728728Gutleb, A.C., Murk, A.J., 2012. Toxicol. Sci. 130, 94e105.
Muusse, M., Christensen, G., Langford, K., Tollefsen, K.-E., Thomas, K.V., 2014.
J. Toxicol. Environ. Heal. Part A 77, 550e556.
Muusse, M., Christensen, G., Gomes, T., Kocan, A., Langford, K., Tollefsen, K.E.,
Vankova, L., Thomas, K.V., 2015. Sci. Total Environ. 514, 211e218.
Ouyang, X., Leonards, P.E.G., Tousova, Z., Slobodnik, J., de Boer, J., Lamoree, M.H.,
2016. Anal. Chem. 88, 2353e2360.
Ren, X.M., Guo, L.-H., 2012. Environ. Sci. Technol. 46, 4633e4640.
Simon, E., van Velzen, M., Brandsma, S.H., Lie, E., Løken, K., de Boer, J., Bytingsvik, J.,
Jenssen, B.M., Aars, J., Hamers, T., Lamoree, M.H., 2013. Environ. Sci. Technol. 47,
8902e8912.Smith, D.S., 1977. FEBS Lett. 77, 25e27.
Suzuki, G., Takigami, H., Nose, K., Takahashi, S., Asari, M., Sakai, S.-I., 2007. Environ.
Sci. Technol. 41, 1487e1493.
Ucan-Marín, F., Arukwe, A., Mortensen, A., Gabrielsen, G.W., Fox, G.A., Letcher, R.J.,
2009. Toxicol. Sci. 107, 440e450.
Verreault, J., Letcher, R.J., Muir, D.C.G., Chu, S., Gebbink, W.A., Gabrielsen, G.W.,
2005. Environ. Toxicol. Chem. 24, 2486e2499.
Weiss, J.M., Andersson, P.L., Lamoree, M.H., Leonards, P.E.G., van Leeuwen, S.P.J.,
Hamers, T., 2009. Toxicol. Sci. 109, 206e216.
Weiss, J.M., Andersson, P.L., Zhang, J., Simon, E., Leonards, P.E.G., Hamers, T.,
Lamoree, M.H., 2015. Anal. Bioanal. Chem. 407, 5625e5634.
